This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (94)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Ten Years' Experience at a University Hospital

Allan J. Morrison, Jr, MD; Richard P. Wenzel, MD

Arch Intern Med. 1986;146(8):1549-1551.

Abstract
• From 1975 through 1984, 473 cases of enterococcal nosocomial urinary tract infection (UTI) were identified by prospective hospital-wide surveillance at the University of Virginia Hospital, Charlottesville. The rate of infection increased progressively from 12.3 to 32.2 cases per 10 000 patient discharges, and the proportion of nosocomial UTIs due to this organism increased from 6% to 16%. During the study period, crude mortality was 15%. Patients with the diagnosis of neurogenic bladder accounted for 26% of cases and had a crude mortality of 7.3%; all other cases (74%) had a crude mortality of 18.1% Risk factors associated with fatal outcome in cases having a nosocomial enterococcal UTI included age of more than 50 years, concurrent acute respiratory failure, hospitalization on the internal medicine service, and concurrent gastrointestinal hemorrhage. Enterococcus is the second most frequent cause of nosocomial UTI in our hospital. The emergence of this pathogen may reflect, in part, its selective advantage imparted by resistance to cephalosporin antibiotics.

(Arch Intern Med 1986;146:1549-1551)

Author Affiliations
From the Department of Internal Medicine, University of Virginia Medical Center, Charlottesville.

Footnotes
Accepted for publication Nov 26, 1985.

Reprint requests to 3299 Woodburn Rd, Suite 220, Annandale, VA 22003 (Dr Morrison).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Antibiotic activity against urinary tract infection (UTI) isolates of vancomycin-resistant enterococci (VRE): results from the 2002 North American Vancomycin Resistant Enterococci Susceptibility Study (NAVRESS)
Zhanel et al.
J Antimicrob Chemother 2003;52:382-388.
ABSTRACT | FULL TEXT  

Vancomycin-Resistant Enterococcal Infections
Murray
NEJM 2000;342:710-721.
FULL TEXT  

Analytic Reviews : Enterococcal Infections: Resistance Mechanisms, Treatment Strategies, and Hospital Issues: Ostrowsky B, Eliopoulos, GM Enterococcal Infections Resistance Mechanisms, Treatment Strategies, and Hospital Issues J Intensive Care Med 1999,14.62-73
Ostrowsky and Eliopoulos
J Intensive Care Med 1999;14:62-73.
 

Cephalosporins as Risk Factor for Nosocomial Enterococcus faecalis Bacteremia: A Matched Case-Control Study
Pallares et al.
Arch Intern Med 1993;153:1581-1586.
ABSTRACT  

Nosocomial Acquisition of {beta}-Lactamase--Negative, Ampicillin-Resistant Enterococcus
Chirurgi et al.
Arch Intern Med 1992;152:1457-1461.
ABSTRACT  

How Long Should Catheter-Acquired Urinary Tract Infection in Women Be Treated? A Randomized Controlled Study
Harding et al.
ANN INTERN MED 1991;114:713-719.
ABSTRACT  

Emergence of Isolates Resistant to Ampicillin
Rupar et al.
Arch Pediatr Adolesc Med 1989;143:1033-1037.
ABSTRACT  

High-Level Aminoglycoside-Resistant Enterococci: Colonization of Nursing Home and Acute Care Hospital Patients
Zervos et al.
Arch Intern Med 1987;147:1591-1594.
ABSTRACT  

The Enterococcus: "Putting the Bug in Our Ears"
HOFFMANN and MOELLERING
ANN INTERN MED 1987;106:757-761.
ABSTRACT